Vor Biopharma Inc.
VOR
$0.5671
-$0.0229-3.88%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -32.99% | -60.77% | -54.02% | -48.87% | -40.42% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 33.24% | 14.40% | 2.38% | -38.60% | -27.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -20.00% | -57.27% | -49.54% | 10.46% | -79.67% |
| Total Current Assets | -31.46% | -59.08% | -52.84% | -48.45% | -40.58% |
|
|
|||||
| Total Current Assets | -31.46% | -59.08% | -52.84% | -48.45% | -40.58% |
| Net Property, Plant & Equipment | -16.99% | -15.97% | -14.94% | -13.44% | -12.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -33.62% | -24.22% | -3.61% | 38.97% | 35.35% |
| Total Assets | -27.88% | -47.99% | -43.59% | -39.82% | -33.82% |
|
|
|||||
| Total Accounts Payable | 84.66% | 0.53% | 21.78% | -27.71% | -54.01% |
| Total Accrued Expenses | 17.98% | -14.22% | 4.42% | 24.10% | 35.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.05% | 11.22% | 11.43% | 6.57% | 17.05% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 19.52% | -6.78% | 8.52% | 5.04% | 18.70% |
|
|
|||||
| Total Current Liabilities | 19.52% | -6.78% | 8.52% | 5.04% | 18.70% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.24% | -12.67% | -12.16% | -11.39% | -10.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -2.48% | -10.79% | -6.51% | -7.02% | -2.78% |
|
|
|||||
| Common Stock & APIC | 12.78% | 2.10% | 2.34% | 2.70% | 3.65% |
| Retained Earnings | -34.38% | -35.84% | -42.08% | -47.97% | -53.04% |
| Treasury Stock & Other | 128.57% | 124.29% | 83.94% | 50.00% | 90.00% |
| Total Common Equity | -35.87% | -58.26% | -52.03% | -46.56% | -39.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -35.87% | -58.26% | -52.03% | -46.56% | -39.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -35.87% | -58.26% | -52.03% | -46.56% | -39.86% |
|
|
|||||
